
Huaguan Biotech
桦冠生物
Huaguan Biotech
Biotech/Healthcare
Huaguan Biotechnology was founded in 2018. It is developing several core technology platforms, including continuous-flow and enzymatic biosynthesis technologies for the green and safe production of active pharmaceutical ingredients, as well as a globally leading “one-arrow-multiple-satellites” ADC…
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.